Evidence map›Paper›PMID 21394469›Full record

ArticlePlanta2011

The roles of ascorbic acid and glutathione in symptom alleviation to SA-deficient plants infected with RNA viruses.

Shao-Dong Wang, Feng Zhu, Shu Yuan, Hui Yang, Fei Xu, Jing Shang, Mo-Yun Xu, Shu-Dan Jia, Zhong-Wei Zhang, Jian-Hui Wang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Planta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 82 citations in OpenAlex.

  1. Frontiers in plant science · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Vitamin C in Plants: From Functions to Biofortification.Antioxidants (Basel, Switzerland) · 2019
    Review
  11. Alleviation ofPlants (Basel, Switzerland) · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Shao-Dong WangPlant Pathology Laboratory, College of Life Science, Sichuan University, Chengdu 610064, China.
Feng Zhu
Shu Yuan
Hui Yang
Fei Xu
Jing Shang
Mo-Yun Xu
Shu-Dan Jia
Zhong-Wei Zhang
Jian-Hui Wang
De-Hui Xi
Hong-Hui Lin
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salicylic acid (SA) is required for plant systemic acquired resistance (SAR) to viruses. However, SA-deficient plants adapt to RNA virus infections better, which show a lighter symptom and have less reactive oxygen species (ROS) accumulation. The virus replication levels are higher in the SA-deficient plants during the first 10 days, but lower than the wild-type seedlings after 20 dpi. The higher level of glutathione and ascorbic acid (AsA) in SA-deficient plants may contribute to their alleviated symptoms. Solo virus-control method for mortal viruses results in necrosis and chlorosis, no matter what level of virus RNAs would accumulate. Contrastingly, early and high-dose AsA treatment alleviates the symptom, and eventually inhibits virus replication after 20 days. ROS eliminators could not imitate the effect of AsA, and could neither alleviate symptom nor inhibit virus replication. It suggests that both symptom alleviation and virus replication control should be considered for plant virus cures.

Indexed as

ArabidopsisAscorbic AcidGlutathioneImmunity, InnatePlant DiseasesPlant VirusesRNA VirusesSalicylic AcidVirus ReplicationAscorbic AcidGlutathioneSalicylic Acid

Identifiers

PMID21394469
OpenAlexW1992733998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.